Bayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Cara Care is a digital digestive health solution from Germany that combines both mental and nutritional therapy options. Its MDR Class I-approved treatment for irritable bowel syndrome (IBS) is fully reimbursed by all German statutory health insurance (SHI) and DiGA-certified providers. DiGA refers to digital health applications that are approved for use in Germany and are eligible for reimbursement under the country’s SHI system. The company is a pioneer in the field and is driving growth in an underserved sector. Cara Care has built a product pipeline that addresses not only IBS but also heartburn, dyspepsia and inflammatory bowel disease (IBD).
Bayer AG is a global enterprise with core competencies in the life sciences fields of healthcare and agriculture. Founded in 1863 and headquartered in Leverkusen, Germany, Bayer is known for its innovation-driven approach to improving quality of life. The company operates across three main divisions: pharmaceuticals, consumer health and crop science, delivering products and solutions that address some of the world’s most pressing challenges, particularly in health and food security.
Oaklins’ team in Germany provided comprehensive advisory services to the insolvency administrator and Cara Care in this transaction.
Sprechen Sie mit dem Deal-Team
Jan P. Hatje
Oaklins Germany
Relevante Transaktionen
NetNordic has acquired Itectra
Norvestor-backed NetNordic has acquired Danish optical network solutions firm Itectra. The transaction marks NetNordic’s 25th acquisition since 2015, further strengthening its position in the Nordic market. It enables NetNordic to expand its market relevance through deeper expertise in optical network solutions, consolidating its standing in larger Nordic projects and creating cross-selling opportunities between NetNordic’s network solutions and Itectra’s optical capabilities.
Weitere InformationenLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Weitere InformationenMatera has acquired a majority stake in Fáciltech
Matera has acquired a controlling stake in Fáciltech. The acquisition represents a strategic step to expand Matera’s client base and strengthen its core banking offering, incorporating specialized operational management and ERP solutions that serve institutions with different profiles and business models.
Weitere Informationen